Near, Aimee M.
Tse, Jenny
Young-Xu, Yinong
Hong, David K.
Reyes, Carolina M.
Article History
Received: 31 January 2022
Accepted: 8 September 2022
First Online: 28 September 2022
Declarations
:
: Not applicable. This was a retrospective database study using de-identified data compliant with the US Health Insurance Portability and Accountability Act of 1996. Therefore, ethics approval from the Institutional Review Board (IRB) was not required for this study.
: Not applicable.
: D.H. and C.R. reports financial support from VIR Biotechnology Inc. Y.Y. reports a relationship with VIR Biotechnology Inc. that includes: funding grants. D.H. reports a relationship with Janssen Pharmaceuticals Inc. that includes: employment. D.H. reports a relationship with VIR Biotechnology Inc. that includes: equity or stocks. C.R. reports a relationship with VIR Biotechnology Inc. that includes: employment and equity or stocks. A.N. and J.T. are employees of IQVIA, which received funding from VIR Biotechnology Inc. to conduct this study.